Order Article Reprints

Kuroda T, Fukao K, Yoshida S, Oka R, Baba K, Ando Y, Taniguchi K, Noshi T, Shishido T. In Vivo Antiviral Activity of Baloxavir against PA/I38T-Substituted Influenza A Viruses at Clinically Relevant Doses. Viruses. 2023; 15(5):1154. https://doi.org/10.3390/v15051154

Kuroda, Takayuki, Keita Fukao, Shinpei Yoshida, Ryoko Oka, Kaoru Baba, Yoshinori Ando, Keiichi Taniguchi, Takeshi Noshi, and Takao Shishido. 2023. "In Vivo Antiviral Activity of Baloxavir against PA/I38T-Substituted Influenza A Viruses at Clinically Relevant Doses" Viruses 15, no. 5: 1154. https://doi.org/10.3390/v15051154

Kuroda, T., Fukao, K., Yoshida, S., Oka, R., Baba, K., Ando, Y., Taniguchi, K., Noshi, T., & Shishido, T. (2023). In Vivo Antiviral Activity of Baloxavir against PA/I38T-Substituted Influenza A Viruses at Clinically Relevant Doses. Viruses, 15(5), 1154. https://doi.org/10.3390/v15051154